NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-242-2012-0-PCT-02 Recurrent Mutation In Mitogen-Activated Protein Kinase Kinase Kinase 5 (MAP3K5) For Diagnosing And Treating Melanoma PCT PCT PCT/US13/063077 Expired
NINDS E-023-2014-0-US-01 Insulin-Like Growth Factor Mimetics For Use In Therapy US 61/885,811 Abandoned
NCI E-003-2007-0-US-15 Engineered Antibody Constant Domain Molecules US DIV 14/043,366 9527903 Issued PDF
NHLBI E-342-2013-0-US-01 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US 61/885,209 Abandoned
NIDCR E-619-2013-0-US-01 METHODS OF MODULATING ERYTHROPOIESIS WITH ARGININE VASOPRESSIN RECEPTOR 1B MOLECULES US 61/885,258 Abandoned
CC E-013-2013-0-EP-05 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND EP National Stage 13814610.5 Issued
CC E-013-2013-0-JP-09 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND JP National Stage 2015-536248 Issued
CC E-013-2013-0-PCT-02 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND. PCT PCT PCT/IB13/059001 Expired
CC E-013-2013-0-IN-06 MULTI-FOCI SONICATIONS FOR HYPERTHERMIA TREATMENTS USING MAGNETIC RESONANCE-GUIDED FOCUSSED ULTRASOUND IN National Stage 2632/CHENP/2015 Pending
NCI E-768-2013-0-US-01 Hyperpolarized Media Transport Vessel US ORD 14/038,948 9874622 Issued PDF
NINDS E-113-2011-0-US-06 Wirelessly Powered MRI Signal Amplification System and Method US National Stage 14/008,133 9864026 Issued PDF
NCI E-766-2013-0-US-01 INTERFERON COMPOSITIONS AND USES THEREOF US 61/883,699 Abandoned
NIDCR E-232-2011-1-PCT-02 METHODS FOR THE DIAGNOSIS AND TREATMENT OF SJOGRENS SYNDROME PCT PCT PCT/US2013/061587 Expired
NHLBI E-214-2012-0-EP-05 Compositions and Methods for the Treatment of Central Nervous System (CNS) Injury EP National Stage 13771750.0 Abandoned
NHLBI E-214-2012-0-PCT-02 Compositions and Methods for the Treatment of Central Nervous System (CNS) Injury PCT PCT PCT/US13/061693 Expired
NHLBI E-006-2014-0-US-01 MRI Compatible 3-D Inracardiac Echography Catheter And System US 61/882,371 Abandoned
NIAID E-530-2013-0-US-01 DESMOLARIS COMPOSITIONS AND METHODS OF USE US 61/882,340 Abandoned
NHLBI E-214-2012-0-AU-03 Compositions and Methods for the Treatment of Central Nervous System (CNS) Injury AU National Stage 2013323679 Abandoned
NIA E-084-2011-0-US-04 COMPOSITIONS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS US National Stage 14/006,954 11059869 Issued PDF
NCI E-106-2006-3-GB-11 T Cell Receptors And Related Materials And Methods Of Use GB EP 13185475.4 Abandoned
NCI E-106-2006-3-DE-09 T Cell Receptors And Related Materials And Methods Of Use DE EP 13185475.4 Abandoned
NCI E-106-2006-3-FR-10 T Cell Receptors And Related Materials And Methods Of Use FR EP 13185475.4 Abandoned
NICHD E-120-2015-0-NZ-17 Method For On-demand Contraception NZ DIV 615430 Issued
NIA E-084-2011-0-JP-07 Compositions and Methods for Enhancing the Pluripotency of Stem Cells JP National Stage 2014-501218 Issued
NIAID E-123-2007-0-US-08 Monoclonal Antibodies That Neutralize Anthrax Toxin US DIV 14/031,508 8961975 Abandoned PDF
NCI E-191-2009-0-US-08 AKT PHOSPHORYLATION AT SER473 AS AN INDICATOR FOR TAXANE-BASED CHEMOTHERAPY US DIV 14/031,699 Abandoned
NHLBI E-089-2013-0-US-01 CHEMICALLY DEFINED CULTURE MEDIUM FOR STEM CELL MAINTENANCE AND DIFFERENTIATION US 61/879,840 Abandoned
NINDS E-547-2013-0-US-01 COMPOSITIONS AND METHODS FOR INHIBITING JC VIRUS (JCV) US 61/879,833 Abandoned
NCI E-291-2012-0-CA-05 M971 Chimeric Antigen Receptors CA National Stage 2889055 Issued
NCI E-291-2012-0-IN-08 M971 Chimeric Antigen Receptors IN National Stage 2344/CHENP/2015 Issued
NCI E-291-2012-0-EP-07 M971 Chimeric Antigen Receptors EP National Stage 13773468.7 Issued
NCI E-291-2012-0-AU-03 M971 Chimeric Antigen Receptors AU National Stage 2013335180 Issued
NCI E-291-2012-0-PCT-02 M971 Chimeric Antigen Receptors PCT PCT PCT/US2013/060332 Expired
NCI E-190-2014-0-US-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS US 61/879,627 Abandoned
NHLBI E-259-2007-0-US-04 Nitrite And Nitrite-methemoglobin Therapy To Detoxify Stroma-free Hemoglobin Based Blood Substitutes US ORD 14/028,850 Abandoned
NCI E-765-2013-0-US-01 Multifunctional RNA Nanoparticles and Methods of Use US 61/878,758 Abandoned
NIAAA E-049-2016-0-CA-04 COMPOUND FOR USE IN PROTECTING SKIN CA National Stage 2905545 Issued
NCI E-236-2012-0-CA-04 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY CA National Stage 2885761 Issued
NIAAA E-049-2016-0-AU-03 COMPOUND FOR USE IN PROTECTING SKIN AU National Stage 2013382361 Issued
NCI E-236-2012-0-CN-05 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY CN National Stage 201380060415.1 Issued
NCI E-236-2012-0-HK-09 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY HK EP 16100885.0 Issued
NCI E-236-2012-0-EP-06 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY EP National Stage 13766859.6 Issued
NCI E-236-2012-0-AU-03 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY AU National Stage 2013324049 Issued
NHGRI E-060-2011-0-US-04 METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFBETA AND RUNXI PROTEINS US National Stage 14/005,534 9446048 Issued PDF
NIAAA E-049-2016-0-PCT-02 COMPOUND FOR USE IN PROTECTING SKIN PCT PCT PCT/EP2013/069189 Expired
NCI E-236-2012-0-PCT-02 MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY PCT PCT PCT/US2013/059883 Expired
CC E-126-2011-0-US-06 Acylation And Alkylation Of Amphipathic Peptides To Improve Their Biological And Therapeutic Properties US National Stage 14/114,386 Abandoned
NIAAA E-049-2016-0-EP-05 COMPOUND FOR USE IN PROTECTING SKIN EP National Stage 13762832.7 Pending
NIAAA E-049-2016-0-JP-07 COMPOUND FOR USE IN PROTECTING SKIN JP National Stage 2015-561958 Pending
NCI E-230-2012-0-CA-04 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 CA National Stage 2884743 Issued